DOCSLIB.ORG

Microarray Bioinformatics and Applications in Oncology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microarray Bioinformatics and Applications in Oncology Microarray Bioinformatics and Applications in Oncology Justine Kate Peeters The work in this thesis was performed in the Department of Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands. The printing of this thesis was financially supported by J.E. Juriaanse Stichting, Rotterdam, The Netherlands The Netherlands Bioinformatics Center (NBIC) Affymetrix Europe Cover: painted by Anne Karin Pettersen Arvola, with compliments of Therese Sorlie Print: Printpartners Ipskamp, Enschede www.ppi.nl Lay-out: Legatron Electronic Publishing, Rotterdam ISBN: 978-90-9023048-1 Copyright © J.K. Peeters All right reserved. No part of this thesis may be reproduced or transmitted in any form, by any means, electronic or mechanical, without the prior written permission of the author, or where appropirate, of the publisher of the articles. Microarray Bioinformatics and Applications in Oncology Toepassingen van bioinformatica en microarray’s in oncologie Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de Prof. dr. S.W.J. Lamberts en volgens besluit van het college voor Promoties De openbare verdediging zal plaatsvinden op Woensdag 11 juni 2008 om 13.45 uur door Justine Kate Peeters geboren te Melbourne, Australia Promotiecommissie Promotor: Prof.dr. P.J. van der Spek Co-promotor: Dr. A.E.M. Schutte Overige leden: Prof.dr. F.G. Grosveld Prof.dr. P.A.E. Sillevis Smitt Prof.dr. L.H.J. Looijenga This thesis is dedicated to my Oma ‘Wilhelmena Johanna Peeters’ (1918-2004). Table of Contents 1 Introduction to Microarray Bioinformatics 11 1.0 Introduction to microarray bioformatics 12 1.1 The age of science and the evolution into the ‘Omics’ era 12 1.2 Microarray technology 13 1.3 Microarray experiment design 15 1.3.1 Biological variation 16 1.3.2 Technical and system variation 16 1.4 Gene Chip technology 18 1.5 Labeling and hybridization procedure 20 1.6 Scanning expression microarrays: converting probe sets to signal intensity 21 1.6.1 Data output from the scanner 21 1.6.2 Normalization and summarization 23 1.6.2.1 Mas normalization 24 1.6.2.2 Quantile normalization 24 1.6.2.3 RMA/RMAexpress 24 1.6.2.4 Normalization by VSN 26 1.6.3 Other Transformations 27 1.6.4 Choice of normalization 28 1.7 Clustering: Unsupervised analysis 29 1.7.1 Hierarchical clustering 29 1.7.2 Partitioning clustering 30 1.7.3 Multi-dimensional clustering 32 1.7.4 Choice of clustering method 35 1.8 Visualization of gene/sample similarity: Pearson correlation matrix 36 1.9 Supervised analysis 36 1.9.1 Class comparison 37 1.9.2 Problem of multiple testing: p-values and false discovery rates 38 1.9.3 Class prediction 39 1.9.4 Cross-validation 40 1.10 Validation of results 40 1.11 Pattern discovery: ontological classification and pathway analysis 40 1.12 Various types of microarray 44 1.12.1 Exon arrays 44 1.13 Bioinformatics bibliography 47 2 Introduction to Cancer 51 2.0 Introduction to Cancer 52 2.1 Cancer 52 2.2 Breast cancer 52 2.2.1 Normal breast histology 52 2.2.2 Malignant breast histology 54 2.2.3 Incidence and risk factors 55 2.2.4 Prognosis and therapy 55 2.3 Brain tumors 56 2.3.1 Brain tumor pathology 56 2.3.2 Incidence and risk factors 56 2.3.3 Prognosis and therapy 57 2.4 The genetics of cancer 57 2.4.1 Accumulation of mutations in several genes 57 2.4.2 Somatic and germline mutations 58 2.4.3 Cancer genes 58 2.4.3.1 Oncogenes 58 2.4.3.2 Tumor Suppressor genes 59 2.4.3.3 Stability genes 59 2.4.3.4 Epigenetic regulation 60 2.4.4 Cancer genes in breast cancer and brain tumors 61 2.4.4.1 EGFR and ERBB2 61 2.4.4.2 TP53 62 2.4.4.3 E-cadherin 62 2.4.4.4 PTEN 63 2.4.4.5 BRCA1, BRCA2 and CHEK2 63 2.5 Gene expression in cancer 65 2.5.1 Gene expression, gene mutations and cell biology 65 2.5.2 Breast cancer gene expression profiles 65 2.5.3 Brain tumor gene expression profiles 68 2.6 Cancer Bibliography 70 3 Growing Applications and Advancements in Microarray Technology 75 and Analysis Tools 4 Epigenetic silencing and mutational inactivation of E-cadherin associate 99 with distinct breast cancer subtypes 5 Gene expression profiling assigns CHEK2 1100delC breast cancers to the 133 luminal intrinsic subtypes 6 Identification of differentially regulated splice-variants and novel exons in 155 glial brain tumors using exon expression arrays 7 Exon expression arrays as a tool to identify new cancer genes 173 8.0 Discussion 190 8.1 Microarray applications to oncology 190 8.2 Considerations on microarray technology 190 8.2.1 Sample variability 190 8.2.2 Technical variability: the probes 191 8.2.3 Reproducibility: different platforms and multiple array comparison 192 8.2.4 Analytical variability 193 8.3 Focused microarray analysis 194 8.4 Considerations on microarray applications in oncology 195 8.4.1 Epigenetic inactivation of E-cadherin by methylation is distinct 195 from genetic inactivation by mutation 8.4.2 A gene signature is associated with CHEK2 1000delC mutations in 196 breast cancer 8.4.3 Exon arrays identify differentially expressed splice variants in brain tumors 198 8.4.4 Exon arrays identify exon-skipping mutations in breast cancer cell 198 lines breast and brain tumors 8.5 The future of microarrays applications in oncology and final conclusions 199 8.6 Discussion bibliography 202 Samenvatting 207 Summary 209 Dankword / Acknowledgements 211 Curriculum vitae 215 List of publications 217 Abbreviations 221 Appendices 1 Natural population dynamics and expansion of pathogenic clones 222 of Staphylococcus aureus 2 http://www-bioinf.erasmusmc.nl/thesis_peeters 231 3 Published interview: Discovery of Novel Splice Variations Improves 232 GlialTumor Classificationc 4 Published interview: Global view of gene expression analysis 237 *For all large supplementary data files, tables and colour versions of figures and PDFs. please refer to the website http://www-bioinf.erasmusmc.nl/thesis_peeters. Chapter 1 Introduction to Microarray Bioinformatics 1.0 Introduction to microarray bioformatics ‘Bioinformatics’ is one of the newest fields of biological research, and should be viewed broadly as the use of mathematical, statistical, and computational methods for the processing and analysis of biologic data [1]. Over the last decade, the rapid growth of information and technology in both ‘genomics1’ and ‘omics2’ era’s has been overwhelming for the laboratory scientists to process experimental results. Traditional gene-by-gene approaches in research are insufficient to meet the growth and demand of biological research in understanding the true biology. The massive amounts of data generated by new technologies as genomic sequencing and microarray chips make the management of data and the integration of multiple platforms of high importance; this is then followed by data analysis and interpretation to achieve biological understanding and therapeutic progress. Global views of analyzing the magnitude of information are necessary and traditional approaches to labwork have steadily been changing towards a bioinformatic era. Research is moving from being restricted to a laboratory environment to working with computers in a ‘virtual lab’ environment. 1.1 The age of science and the evolution into the ‘Omics’ era The invention of the Polymerase Chain Reaction (PCR) technique was a major milestone in molecular research that transformed and revolutionized current research and diagnostics [3]. Since the introduction of PCR, linkage analysis and mutation screening became easier and the rate of identified disease genes increased dramatically. Another milestone that influenced the rate of discovery was the Human Genome project [4,5]. The main aim of this project was to create a detailed physical map of the human genome. Having genomic sequences available made the identification of disease related mutations in Mendelian single gene disorders an easier task; however, the mapping of complex diseases such as diabetes and cancer remains a challenge. The successful completion of the Human Genome Project, as well as the sequencing of the genomes of many other species, has generated a large amount of freely available information, opening the 1 The study of all of the nucleotide sequences, including structural genes, regulatory sequences, and non-coding DNA segments, in the chromosomes of an organism. Also seen as a branch of biotechnology concerned with applying the techniques of genetics and molecular biology to the genetic mapping and DNA sequencing of sets of genes or the complete genomes of selected organisms using high-speed methods, with organizing the results in databases, and with applications of the data (as in medicine or biology) 2. http://www.dictionary.com. [cited. 2 ‘Omics’ refers to a field of study in biology ending in the suffix -omics such as genomics or proteomics. The related neologism ‘omes’ addresses the objects of study of such fields, such as the genome or proteome respectively 2. Ibid. [cited.. 12 Introduction to Microarray Bioformatics Chapter door to a post-genome era where an ‘e-science’ approach can allow in silico research and further 1 mining of available data. One of the most challenging objectives of the post-genome era is to understand the complex genome and its interacting products. Various techniques to understand gene expression have been developed where it is important to remember that RNA (ribonucleic acid) expression does not directly reflect equal protein levels. Approaches such as subtractive hybridization of cDNA libraries and differential display have been used with some success; however, these techniques are laborious and are not suited for global gene analysis.
Load more

Recommended publications
  • Association Analyses of Known Genetic Variants with Gene
    ASSOCIATION ANALYSES OF KNOWN GENETIC VARIANTS WITH GENE EXPRESSION IN BRAIN by Viktoriya Strumba A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Bioinformatics) in The University of Michigan 2009 Doctoral Committee: Professor Margit Burmeister, Chair Professor Huda Akil Professor Brian D. Athey Assistant Professor Zhaohui S. Qin Research Statistician Thomas Blackwell To Sam and Valentina Dmitriy and Elizabeth ii ACKNOWLEDGEMENTS I would like to thank my advisor Professor Margit Burmeister, who tirelessly guided me though seemingly impassable corridors of graduate work. Throughout my thesis writing period she provided sound advice, encouragement and inspiration. Leading by example, her enthusiasm and dedication have been instrumental in my path to becoming a better scientist. I also would like to thank my co-advisor Tom Blackwell. His careful prodding always kept me on my toes and looking for answers, which taught me the depth of careful statistical analysis. His diligence and dedication have been irreplaceable in most difficult of projects. I also would like to thank my other committee members: Huda Akil, Brian Athey and Steve Qin as well as David States. You did not make it easy for me, but I thank you for believing and not giving up. Huda’s eloquence in every subject matter she explained have been particularly inspiring, while both Huda’s and Brian’s valuable advice made the completion of this dissertation possible. I would also like to thank all the members of the Burmeister lab, both past and present: Sandra Villafuerte, Kristine Ito, Cindy Schoen, Karen Majczenko, Ellen Schmidt, Randi Burns, Gang Su, Nan Xiang and Ana Progovac.
    [Show full text]
  • BMC Cell Biology Biomed Central
    BMC Cell Biology BioMed Central Research article Open Access Nuclear envelope transmembrane proteins (NETs) that are up-regulated during myogenesis I-Hsiung Brandon Chen, Michael Huber, Tinglu Guan, Anja Bubeck and Larry Gerace* Address: Department of Cell Biology, The Scripps Research Institute, 10555 N. Torrey Pines Rd., La Jolla CA 92037, USA Email: I-Hsiung Brandon Chen - [email protected]; Michael Huber - [email protected]; Tinglu Guan - [email protected]; Anja Bubeck - [email protected]; Larry Gerace* - [email protected] * Corresponding author Published: 24 October 2006 Received: 01 September 2006 Accepted: 24 October 2006 BMC Cell Biology 2006, 7:38 doi:10.1186/1471-2121-7-38 This article is available from: http://www.biomedcentral.com/1471-2121/7/38 © 2006 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The nuclear lamina is a protein meshwork lining the inner nuclear membrane, which contains a polymer of nuclear lamins associated with transmembrane proteins of the inner nuclear membrane. The lamina is involved in nuclear structure, gene expression, and association of the cytoplasmic cytoskeleton with the nucleus. We previously identified a group of 67 novel putative nuclear envelope transmembrane proteins (NETs) in a large-scale proteomics analysis. Because mutations in lamina proteins have been linked to several human diseases affecting skeletal muscle, we examined NET expression during differentiation of C2C12 myoblasts.
    [Show full text]
  • The Influence of Genetic Variation in Gene Expression
    The Influence of Genetic Variation in Gene Expression Eva King-Fan Chan A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy 2007 School of Biotechnology and Biomolecular Sciences University of New South Wales Certificate of originality I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at UNSW or any other educational institution, except where due acknowledgement is made in the thesis. Any contribution made to the research by others, with whom I have worked at UNSW or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project's design and conception or in style, presentation and linguistic expression is acknowledged. ______________________ Eva Chan 18th July 2007 i Abstract Abstract Variations in gene expression have long been hypothesised to be the major cause of individual differences. An initial focus of this research thesis is to elucidate the genetic regulatory architecture of gene expression. Expression quantitative trait locus (eQTL) mapping analyses have been performed on expression levels of over 22,000 mRNAs from three tissues of a panel of recombinant inbred mice. These analyses are “single-locus” where “linkage” (i.e. significant correlation) between an expression trait and a putative eQTL is considered independently of other loci.
    [Show full text]
  • MALDI MS Imaging of FFPE Tissues REVIEW Gorzolka and Walch Histology and Histopathology Final
    Title: MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research Karin Gorzolka1, Axel Walch1 1Institute of Pathology, Research Unit Analytical Pathology Helmholtz Zentrum Muenchen National Research Centre for Environment and Health, Ingolstädter Landstraße 1 85764 Neuherberg, Germany Corresponding author: Axel Walch, MD. eMail: [email protected]; phone: +49 89 3187-2739 HISTOPAHTOLOGY manuscript) AND (non-edited HISTOLOGY 1 Abstract The molecular investigation of archived formalin-fixed, paraffin-embedded (FFPE) tissue samples provides the chance to obtain molecular patterns as indicatives for treatment and clinical end points. MALDI mass spectrometry imaging is capable of localizing molecules like proteins and peptides in tissue sections and became a favorite platform for the targeted and non-targeted approaches, especially in clinical investigations for biomarker research. In FFPE tissues the recovery of proteomic information is constrained by fixation-induced cross-links of proteins. The promising new insights obtained from FFPE in combination with the comprehensive patients’ data caused much progress in the optimization of MS imaging protocols to investigate FFPE samples. This review presents the past and current research in MALDI MS imaging of FFPE tissues, demonstrating the improvement of analyses, their actual limitations, but also the promising future perspectives for histopathological and tissue-based research. Key words FFPE (formalin-fixed, paraffin-embedded), mass spectrometry imaging, MALDI, proteins, peptides Introduction HISTOPAHTOLOGY Formalin fixation became a routine measure for the longmanuscript)-term storage of tissues in clinical settings after its first report in 1893 (Blum, 1893). It sustains the tissue integrity for years (Casadonte & Caprioli, 2011) and biomolecules like proteins, DNA, and RNA can be extracted (Ralton & Murray, 2011; Frankel,AND 2012).
    [Show full text]
  • Snapshot: the Nuclear Envelope II Andrea Rothballer and Ulrike Kutay Institute of Biochemistry, ETH Zurich, 8093 Zurich, Switzerland
    SnapShot: The Nuclear Envelope II Andrea Rothballer and Ulrike Kutay Institute of Biochemistry, ETH Zurich, 8093 Zurich, Switzerland H. sapiens D. melanogaster C. elegans S. pombe S. cerevisiae Cytoplasmic filaments RanBP2 (Nup358) Nup358 CG11856 NPP-9 – – – Nup214 (CAN) DNup214 CG3820 NPP-14 Nup146 SPAC23D3.06c Nup159 Cytoplasmic ring and Nup88 Nup88 (Mbo) CG6819 – Nup82 SPBC13A2.02 Nup82 associated factors GLE1 GLE1 CG14749 – Gle1 SPBC31E1.05 Gle1 hCG1 (NUP2L1, NLP-1) tbd CG18789 – Amo1 SPBC15D4.10c Nup42 (Rip1) Nup98 Nup98 CG10198 Npp-10N Nup189N SPAC1486.05 Nup145N, Nup100, Nup116 Nup 98 complex RAE1 (GLE2) Rae1 CG9862 NPP-17 Rae1 SPBC16A3.05 Gle2 (Nup40) Nup160 Nup160 CG4738 NPP-6 Nup120 SPBC3B9.16c Nup120 Nup133 Nup133 CG6958 NPP-15 Nup132, Nup131 SPAC1805.04, Nup133 SPBP35G2.06c Nup107 Nup107 CG6743 NPP-5 Nup107 SPBC428.01c Nup84 Nup96 Nup96 CG10198 NPP-10C Nup189C SPAC1486.05 Nup145C Outer NPC scaffold Nup85 (PCNT1) Nup75 CG5733 NPP-2 Nup-85 SPBC17G9.04c Nup85 (Nup107-160 complex) Seh1 Nup44A CG8722 NPP-18 Seh1 SPAC15F9.02 Seh1 Sec13 Sec13 CG6773 Npp-20 Sec13 SPBC215.15 Sec13 Nup37 tbd CG11875 – tbd SPAC4F10.18 – Nup43 Nup43 CG7671 C09G9.2 – – – Centrin-21 tbd CG174931, CG318021 R08D7.51 Cdc311 SPCC1682.04 Cdc311 Nup205 tbd CG11943 NPP-3 Nup186 SPCC290.03c Nup192 Nup188 tbd CG8771 – Nup184 SPAP27G11.10c Nup188 Central NPC scaffold Nup155 Nup154 CG4579 NPP-8 tbd SPAC890.06 Nup170, Nup157 (Nup53-93 complex) Nup93 tbd CG7262 NPP-13 Nup97, Npp106 SPCC1620.11, Nic96 SPCC1739.14 Nup53(Nup35, MP44) tbd CG6540 NPP-19 Nup40 SPAC19E9.01c
    [Show full text]
  • Limma: Linear Models for Microarray and RNA-Seq Data User’S Guide
    limma: Linear Models for Microarray and RNA-Seq Data User's Guide Gordon K. Smyth, Matthew Ritchie, Natalie Thorne, James Wettenhall, Wei Shi and Yifang Hu Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia First edition 2 December 2002 Last revised 14 July 2021 This free open-source software implements academic research by the authors and co-workers. If you use it, please support the project by citing the appropriate journal articles listed in Section 2.1. Contents 1 Introduction 5 2 Preliminaries 7 2.1 Citing limma ......................................... 7 2.2 Installation . 9 2.3 How to get help . 9 3 Quick Start 11 3.1 A brief introduction to R . 11 3.2 Sample limma Session . 12 3.3 Data Objects . 13 4 Reading Microarray Data 15 4.1 Scope of this Chapter . 15 4.2 Recommended Files . 15 4.3 The Targets Frame . 15 4.4 Reading Two-Color Intensity Data . 17 4.5 Reading Single-Channel Agilent Intensity Data . 19 4.6 Reading Illumina BeadChip Data . 19 4.7 Image-derived Spot Quality Weights . 20 4.8 Reading Probe Annotation . 21 4.9 Printer Layout . 22 4.10 The Spot Types File . 22 5 Quality Assessment 24 6 Pre-Processing Two-Color Data 26 6.1 Background Correction . 26 6.2 Within-Array Normalization . 28 6.3 Between-Array Normalization . 30 6.4 Using Objects from the marray Package . 33 7 Filtering unexpressed probes 34 1 8 Linear Models Overview 36 8.1 Introduction . 36 8.2 Single-Channel Designs . 37 8.3 Common Reference Designs .
    [Show full text]
  • Snp Associations with Tuberculosis Susceptibility in a Ugandan
    SNP ASSOCIATIONS WITH TUBERCULOSIS SUSCEPTIBILITY IN A UGANDAN HOUSEHOLD CONTACT STUDY by ALLISON REES BAKER Submitted in partial fulfillment of the requirements For the degree of Master of Science Thesis Advisor: Dr. Catherine M. Stein Department of Epidemiology and Biostatistics CASE WESTERN RESERVE UNIVERSITY August, 2010 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of ______________________________________________________ candidate for the ________________________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents Table of Contents...............................................................................................................iii List of Tables ..................................................................................................................... iv Acknowledgements............................................................................................................. v List of Commonly Used Abbreviations ............................................................................. vi Chapter 1: Literature
    [Show full text]
  • Protein Microarray Technology: Assisting Personalized Medicine in Oncology (Review)
    WORLD ACADEMY OF SCIENCES JOURNAL 1: 113-124, 2019 Protein microarray technology: Assisting personalized medicine in oncology (Review) MONICA NEAGU1-3, MARINELA BOSTAN1,4 and CAROLINA CONSTANTIN1,2 1Department of Immunology, ‘Victor Babes’ National Institute of Pathology, 050096 Bucharest; 2Research Core of The Pathology Department, Colentina University Hospital, Bucharest 020125; 3Faculty of Biology, University of Bucharest, 050095 Bucharest; 4Immunology Center, ‘Stefan Nicolau’ Institute of Virology, 030304 Bucharest, Romania Received April 23, 2019; Accepted June 11, 2019 DOI: 10.3892/wasj.2019.15 Abstract. Among proteomics technologies, protein microarray, into the future. We present personalized medicine goals and over the past last years, has gained an increased momentum discuss how protein microarray can aid in these goals, with an in the biomarkers discovery domain. The characteristics of emphasis on several oncological diseases. We also discuss how protein microarray, namely that it is a high-throughput tool, it protein technology has been used in diseases, such as lung, provides a high specificity and only requires a minute amount breast cancers, as well as in other diseases that, over the past of biological samples, render it a suitable tool for searching, last years, have taken advantage of this proteomic endeavor. quantifying and validating biomarkers in various pathologies. Protein microarray is based on the specific antigen‑antibody reaction, such as any enzyme-linked immunosorbent assay, Contents the specific reaction occurring on a miniaturized support (chip or slide), thus having the advantage of simultaneous eval- 1. Introduction uation of tens to thousands of molecules in small samples with 2. Personalized medicine: A step forward in improving a highly specific recognition for the detection system.
    [Show full text]
  • Perspectives
    FOCUS ON MECHANOTRANSDUCTION PERSPECTIVES network that can promote coordinated OPINION changes in cell, cytoskeletal and nuclear struc- ture in response to mechanical distortion14 Mechanotransduction at a (FIG. 1a). (Herein, the term hard-wired refers to cytoskeletal structures that are stable enough distance: mechanically coupling the as interconnected units to resist mechanical stresses and thereby maintain shape stabil- ity, even though they undergo continuous extracellular matrix with the nucleus dynamic remodelling at the molecular level.) This model takes into account the observa- Ning Wang, Jessica D. Tytell and Donald E. Ingber tion that individual cytoskeletal filaments can bear significant tensile and compressive loads Abstract | Research in cellular mechanotransduction often focuses on how in living cells because their structural integrity extracellular physical forces are converted into chemical signals at the cell surface. is maintained for longer than the turnover However, mechanical forces that are exerted on surface-adhesion receptors, such time of individual protein monomers15–17. as integrins and cadherins, are also channelled along cytoskeletal filaments and Key to the cellular tensegrity model is concentrated at distant sites in the cytoplasm and nucleus. Here, we explore the the idea that overall cell-shape stability and long-distance force transfer are governed by molecular mechanisms by which forces might act at a distance to induce the level of isometric tension, or ‘prestress’, mechanochemical conversion in the nucleus and alter gene activities. in the cytoskeleton that is generated through the establishment of a force balance between Mechanical forces influence the growth and For example, endothelial cells sense fluid opposing structural elements (that is, micro- shape of virtually every tissue and organ in shear through a cell–cell junctional com- tubules, contractile microfilaments and our bodies.
    [Show full text]
  • The SUN Rises on Meiotic Chromosome Dynamics
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Cell Review Feature The SUN Rises on Meiotic Chromosome Dynamics Yasushi Hiraoka1,2,* and Abby F. Dernburg3,4,* 1Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamadaoka, Suita 565-0871, Japan 2Kobe Advanced ICT Research Center, National Institute of Information and Communications Technology, 588-2 Iwaoka, Iwaoka-cho, Nishi-ku, Kobe 651-2492, Japan 3Howard Hughes Medical Institute and Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720-3220, USA 4Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA *Correspondence: [email protected] (Y.H.), [email protected] (A.F.D.) DOI 10.1016/j.devcel.2009.10.014 Recent studies in diverse eukaryotes have implicated a family of nuclear envelope proteins containing SUN domains as key components of meiotic nuclear organization and chromosome dynamics. In many cases, these transmembrane proteins are also known to contribute to centrosome or spindle pole body function in mitotically dividing cells. During meiotic prophase, the apparent role of these SUN-domain proteins, together with their partner KASH-domain proteins, is to connect chromosomes through the intact nuclear envelope to force-generating mechanisms in the cytoplasm. A Family of SUN Proteins In this review, we use these existing names and also refer to these The SUN domain was named for homologous sequences shared genes and their orthologs in mouse and human genomes as Sun4 by Sad1 and UNC-84 proteins (Malone et al., 1999).
    [Show full text]
  • Breast Pathology
    28A ANNUAL MEETING ABSTRACTS Breast Pathology Clincopathologic parameters n=68(%) Predominant MC 101 Overexpression of FoxO3a Is Associated with Lymph Node Squamous 31(45.5) Metastasis and Poor Disease-Free Survival in Triple-Negative Breast Spindle 15(22) Cancers Chondroid 9(13) Rehman Abdul, Yumin Chung, Hyein Ahn, Jongmin Sim, Min Sung Chung, Kiseok Jang. Osseous 4(6) Hanyang University College of Medicine, Seoul, Republic of Korea. Background: Triple negative breast cancer (TNBC) is the most aggressive type of breast Pseudoangiomatous 6(9) cancer, whichis a heterogeneous group and has no proven molecular target. FoxO3a, Mixed 2(3) a transcription factor, is involved in wide spectrum of biological processes, including HG sarcomatoid 1(1.5) cell cycle progression, proliferation, DNA damage repair, and apoptosis.Recently, DCIS with metaplastic features 14(52) accumulating evidences suggests that FoxO3a act as a tumor suppressorin variety Squamous 11(78.5) of human cancers. However,the previous studies usingTNBC cell lines have shown controversial results. The aim of this study was to investigate the clinicopathological Chondroid 2(14) significance and role of FoxO3a in the progression of TNBC. Rhabdoid 1(7.5) Design: Tissue microarrays consisting of 124 cases of TNBC were studied for FoxO3a None 13(48) expression by immunohistochemistry and interpreted by semi-quantitative scoring Grade system. The FoxO3a expression correlated with various clinicopathological parameters, 1 1(1.5) including patient’s survival. Furthermore, cultured TNBC cell lines (MDA-MB-231, MDA-MB-468, BT20) were assessed for FoxO3a expression by western blot. MDA- 2 3(4.5) MB-468 breast cancer cell line was transiently transfected with exogenous siRNA, 3 64(94) which wasspecific for FoxO3a.
    [Show full text]
  • Tissue Microarray Kathleen Barrette1, Joost J
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector RESEARCH TECHNIQUES MADE SIMPLE Tissue Microarray Kathleen Barrette1, Joost J. van den Oord2 and Marjan Garmyn1 Journal of Investigative Dermatology (2014) 134, e24. doi:10.1038/jid.2014.277 INTRODUCTION The tissue microarray (TMA) technique has been in use for 15 ADVANTAGES years. The technology was first described in 1987, but its use • Allows high-throughput analysis of multiple took off 11 years later, when Kononen and colleagues devel- specimens at the same time. oped a device that could rapidly and reproducibly produce • Allows semiquantitative scoring of et al. TMAs (Kononen , 1998). This powerful, high-throughput immunohistochemical or hybridization signals. technique can be used to assay hundreds of patient tissues arrayed on a single microscope slide. • Allows use of minimal quantities of tissue. THE TECHNIQUE LIMITATIONS Following fixation, biopsies and excised tissue samples are usu- • Cores may not be representative of the whole tumor ally embedded in paraffin blocks to facilitate their cutting on a owing to tumor heterogeneity; in a heterogeneous microtome; this results in 5-µm tissue slides that can be stained tumor, multiple cores must be taken. with hematoxylin and eosin (H&E) and viewed under a micro- scope. The paraffin blocks can also be used as source of material • Requires experienced personnel and expensive from which to construct a TMA. In this procedure, areas of inter- equipment. est are marked on the H&E slides by a pathologist. Then, cylin- drical tissue core biopsy specimens (Figure 1a) from the original formalin-fixed paraffin-embedded (FFPE) tissue donor blocks are punched out of the paraffin block using specialized TMA equip- APPLICATIONS ment and placed in a predrilled hole in a (new) recipient paraf- The increased use of new molecular biology techniques has fin block at defined array coordinates (Jawhar, 2009; Camp et revolutionized investigation of the pathogenesis and progres- al., 2008).
    [Show full text]